Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meng Cheng

Showing results (511-520 of 552) with videos related to

Pageof 56
Sort By:
Journal of the American Heart Association|October 7, 2017
Inhibiting Histone Deacetylase 2 (HDAC2) Promotes Functional Recovery From StrokeYing Tang, Yu-Hui Lin, Huan-Yu Ni, et al.
Plos One|January 23, 2016
MicroRNA-134 Contributes to Glucose-Induced Endothelial Cell Dysfunction and This Effect Can Be Reversed by Far-Infrared IrradiationHsei-Wei Wang, Shu-Han Su, Yen-Li Wang, et al.
Journal of Vascular Research|January 26, 2017
Dysregulation of Vascular Endothelial Growth Factor Receptor-2 by Multiple miRNAs in Endothelial Colony-Forming Cells of Coronary Artery DiseaseShu-Han Su, Chun-Hsien Wu, Ya-Lin Chiu, et al.
Inflammation|February 6, 2024
The Angiotensin II Receptor Neprilysin Inhibitor LCZ696 Inhibits the NLRP3 Inflammasome By Reducing Mitochondrial Dysfunction in Macrophages and Alleviates Dextran Sulfate Sodium-induced Colitis in a Mouse ModelHsiao-Wen Chiu, Chun-Hsien Wu, Wen-Yu Lin, et al.
Frontiers in Immunology|June 7, 2022
Repositioning of the Angiotensin II Receptor Antagonist Candesartan as an Anti-Inflammatory Agent With NLRP3 Inflammasome Inhibitory ActivityWen-Yu Lin, Lan-Hui Li, Ya-Yun Hsiao, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|February 14, 2014
Impact of renal dysfunction on clinical outcome in patients with low risk of atrial fibrillationWen-Yu Lin, Yenn-Jiang Lin, Fa-Po Chung, et al.
Nature|May 31, 2023
Uncovering the Ediacaran phosphorus cycleMatthew S Dodd, Wei Shi, Chao Li, et al.
Neurology. Genetics|June 6, 2024
Disease Progression and Multiparametric Imaging Characteristics of Spinocerebellar Ataxia Type 3 With Spastic ParaplegiaZhi-Xian Ye, Hao-Ling Xu, Na-Ping Chen, et al.
Orphanet Journal of Rare Diseases|January 24, 2025
Associations between CAG repeat size, brain and spinal cord volume loss, and motor symptoms in spinocerebellar ataxia type 3: a cohort studyZhi-Xian Ye, Xuan-Yu Chen, Meng-Cheng Li, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 9, 2017
Opening a New Time Window for Treatment of Stroke by Targeting HDAC2Yu-Hui Lin, Jian Dong, Ying Tang, et al.
Pageof 56

Showing results (511-520 of 552) with videos related to

Sort By:
Pageof 56
Journal of the American Heart Association|October 7, 2017
Inhibiting Histone Deacetylase 2 (HDAC2) Promotes Functional Recovery From StrokeYing Tang, Yu-Hui Lin, Huan-Yu Ni, et al.
Plos One|January 23, 2016
MicroRNA-134 Contributes to Glucose-Induced Endothelial Cell Dysfunction and This Effect Can Be Reversed by Far-Infrared IrradiationHsei-Wei Wang, Shu-Han Su, Yen-Li Wang, et al.
Journal of Vascular Research|January 26, 2017
Dysregulation of Vascular Endothelial Growth Factor Receptor-2 by Multiple miRNAs in Endothelial Colony-Forming Cells of Coronary Artery DiseaseShu-Han Su, Chun-Hsien Wu, Ya-Lin Chiu, et al.
Inflammation|February 6, 2024
The Angiotensin II Receptor Neprilysin Inhibitor LCZ696 Inhibits the NLRP3 Inflammasome By Reducing Mitochondrial Dysfunction in Macrophages and Alleviates Dextran Sulfate Sodium-induced Colitis in a Mouse ModelHsiao-Wen Chiu, Chun-Hsien Wu, Wen-Yu Lin, et al.
Frontiers in Immunology|June 7, 2022
Repositioning of the Angiotensin II Receptor Antagonist Candesartan as an Anti-Inflammatory Agent With NLRP3 Inflammasome Inhibitory ActivityWen-Yu Lin, Lan-Hui Li, Ya-Yun Hsiao, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|February 14, 2014
Impact of renal dysfunction on clinical outcome in patients with low risk of atrial fibrillationWen-Yu Lin, Yenn-Jiang Lin, Fa-Po Chung, et al.
Nature|May 31, 2023
Uncovering the Ediacaran phosphorus cycleMatthew S Dodd, Wei Shi, Chao Li, et al.
Neurology. Genetics|June 6, 2024
Disease Progression and Multiparametric Imaging Characteristics of Spinocerebellar Ataxia Type 3 With Spastic ParaplegiaZhi-Xian Ye, Hao-Ling Xu, Na-Ping Chen, et al.
Orphanet Journal of Rare Diseases|January 24, 2025
Associations between CAG repeat size, brain and spinal cord volume loss, and motor symptoms in spinocerebellar ataxia type 3: a cohort studyZhi-Xian Ye, Xuan-Yu Chen, Meng-Cheng Li, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 9, 2017
Opening a New Time Window for Treatment of Stroke by Targeting HDAC2Yu-Hui Lin, Jian Dong, Ying Tang, et al.
Pageof 56